Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEAC-102 with FOLFOX + Bevacizumab/Cetuximab in Advanced Colorectal Cancer
NCT02826837Phase 2Unknown
- Sponsor
- Taiwan Leader Biotech Corp.
- Start
- Sep 2022
- Primary completion
- Feb 2024
- Modality
- Small Molecules, Microbial Metabolites
01
Overview
A Phase 2 trial of antrodia camphorata extract in colorectal cancer (CRC), sponsored by Taiwan Leader Biotech Corp.. Status: unknown.
02
Drugs
antrodia camphorata extract
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT02826837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02826837.